Hepatology
Article
How best to manage chronic cholestasis
Here's how to maximize your use of lab work and imaging techniques to identify the source of your patient's cholestasis and provide prompt...
News
Insurer denials of DAA therapy for HCV on the rise
About one in three patients had lack of fill approval by insurers.
News
NASH rapidly overtaking hepatitis C as cause of liver cancer
The analysis is based on National Health and Nutrition Examination Survey and the Organ Procurement and Transplantation Network data.
CE/CME
December 2017: Click for Credit
Topics include: Recurrent strep throat • Motivational pharmacotherapy for minority patients with depression • Revised Bethesda System thyroid...
Article
NASH did not increase risk of poor liver transplantation outcomes
Liver transplants were as successful in NASH patients as in other liver transplant recipients, despite having more comorbidities.
News
FDA approves new treatment for adults with HCV
Results of two trials showed that 96%-97% of patients who received Vosevi had no virus detected in the blood 12 weeks after finishing treatment
Opinion
Hepatitis C is a pediatric disease now
The baby looked perfect: healthy term male, weight at the 60th percentile, normal exam. The mother, a 26-year-old diagnosed with hepatitis C virus...
News
Liver disease doubles risk of colorectal cancer
New screening recommendations for patients with chronic liver diseases are now being considered.
Conference Coverage
Long-term albumin shows survival benefit in decompensated cirrhosis
AMSTERDAM – The ANSWER study showed long-term albumin administration to patients with decompensated cirrhosis may be seen as a disease-modifying...
News
Eliminating hepatitis in the United States: A road map
A new report shows how deaths and new infections can be slashed, but some question whether the political will is there.